One hypothesis to explain this phenomenon is that a robust immune response against mutated proteins in the tumor, resulting in the production of multiple autoantibodies (such as anti-Sp4 and anti-CCAR1), might prevent tumor cells from evading immune surveillance and could potentially lead to their complete eradication. This evidence concerns the gene CCAR1 and neoplasm.